Recent News

• 05.28.2026 - CRISPR Therapeutics to Participate in Upcoming Investor Conferences
• 05.06.2026 - CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
• 05.04.2026 - CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
• 04.07.2026 - CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

Recent Filings

• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.14.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.04.2026 - EX-99.1 EX-99.1
• 05.04.2026 - 8-K Current report
• 05.04.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.21.2026 - ARS Annual Report to Security Holders
• 04.21.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.21.2026 - DEF 14A Other definitive proxy statements
• 04.02.2026 - PRE 14A Other preliminary proxy statements